More articles from Bronchiectasis

Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies
Megan L. Crichton, Mike Lonergan, Alan F. Barker, Oriol Sibila, Pieter Goeminne, Amelia Shoemark, James D. Chalmers

European Respiratory Journal Jul 2020, 56 (1) 2000608; DOI: 10.1183/13993003.00608-2020
Association between physical activity and risk of hospitalisation in bronchiectasis
Victoria Alcaraz-Serrano, Elena Gimeno-Santos, Giulia Scioscia, Albert Gabarrús, Adria Navarro, Beatriz Herrero-Cortina, Rosanel Amaro, Laia Fernández-Barat, Antoni Torres

European Respiratory Journal Jun 2020, 55 (6) 1902138; DOI: 10.1183/13993003.02138-2019
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
Emily Henkle, Jeffrey R. Curtis, Lang Chen, Benjamin Chan, Timothy R. Aksamit, Charles L. Daley, David E. Griffith, Kevin L. Winthrop

European Respiratory Journal Jul 2019, 54 (1) 1801896; DOI: 10.1183/13993003.01896-2018
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Amelia Shoemark, Erin Cant, Luis Carreto, Alexandria Smith, Martina Oriano, Holly R. Keir, Lidia Perea, Elisabet Canto, Leonardo Terranova, Silvia Vidal, Kelly Moffitt, Stefano Aliberti, Oriol Sibila, James D. Chalmers

European Respiratory Journal Jun 2019, 53 (6) 1900303; DOI: 10.1183/13993003.00303-2019
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis
David Araújo, Michal Shteinberg, Stefano Aliberti, Pieter C. Goeminne, Adam T. Hill, Thomas C. Fardon, Dusanka Obradovic, Glenda Stone, Marion Trautmann, Angela Davis, Katerina Dimakou, Eva Polverino, Anthony De Soyza, Melissa J. McDonnell, James D. Chalmers

European Respiratory Journal Feb 2018, 51 (2) 1701953; DOI: 10.1183/13993003.01953-2017
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson

European Respiratory Journal Jan 2018, 51 (1) 1702053; DOI: 10.1183/13993003.02053-2017
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Anthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson

European Respiratory Journal Jan 2018, 51 (1) 1702052; DOI: 10.1183/13993003.02052-2017
Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial
Gerard Muñoz, Javier de Gracia, Maria Buxó, Antonio Alvarez, Montserrat Vendrell

European Respiratory Journal Jan 2018, 51 (1) 1701926; DOI: 10.1183/13993003.01926-2017
Correlates and assessment of excess cardiovascular risk in bronchiectasis
Aarash D. Saleh, Bessie Kwok, Jeremy S. Brown, John R. Hurst

European Respiratory Journal Nov 2017, 50 (5) 1701127; DOI: 10.1183/13993003.01127-2017
The development and validation of the Bronchiectasis Health Questionnaire
Arietta Spinou, Richard J. Siegert, Wei-jie Guan, Amit S. Patel, Harry R. Gosker, Kai K. Lee, Caroline Elston, Michael R. Loebinger, Robert Wilson, Rachel Garrod, Surinder S. Birring

European Respiratory Journal May 2017, 49 (5) 1601532; DOI: 10.1183/13993003.01532-2016

Main menu

User menu

Search

More articles from Bronchiectasis

Pages

Contact us